Cargene Therapeutics
PrivateLast Round
Early Funding
Dec 14, 2021
Total Funding Raised
$19.2M
Company Overview
Cargene Therapeutics is a biotechnology company that develops innovative oligonucleotide therapeutics for liver, cardiometabolic, and ophthalmic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cargene Therapeutics Comparables
Compare Cargene Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanegene Bio | 85% | |
| Rona Therapeutics | 83% | |
| Switch Therapeutics | 81% | |
Cargene Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 14, 2021 |
Cargene Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Early Funding |
| Hyfinity Investments | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2024
Monthly visitors increased 287% MoM, from 310 to 1.2K.
- Oct 29, 2024
Monthly visitors grew 123% MoM, from 139 to 310.
Cargene Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cargene Therapeutics's valuation, stock price, and market status.